by David Z. D'Argenio, Ph.D.
Table of Contents
Mechanism-Based
PK/PD
Physiological
Modeling of the Small Intestine in Drug Absorption
K.S.
Pang
Intracellular
Metabolism of Lamivudine
Z.
Zhou, D.Z. D'Argenio, B.L. Robbins and J.H. Rodman
Mechanism-Based
Pharmacodynamic
Modeling for Prediction of Exposure Response
M.
Danhof, P.H. van der Graaf, S.A.G. Visser and K.P. Zuideveld
Mechanism-Based
PK/PD Modeling of
Digoxin: Role of Receptor Heterogeneity and Postreceptor Events
M.
Weiss and W. Kang
Pharmacodynamics
and Pharmacogenomics
of Corticosteroids: Microarray Studies
W.J.
Jusko, Jin Y. Jin, D.C. DuBois and R.R. Almon
Bayesian
Inference in
Physiologically-Based Pharmacokinetic Modeling: Application to
Anticancer Drug Development
L.
Xu, D.Z. D'Argenio, J.L. Eiseman and M.J.Egorin
Pharmacometrics
Monte Carlo Parametric Expectation Maximization (MC-PEM)
Method for
Analyzing Population Pharmacokinetic/Pharmacodynamic Data
R.J.
Bauer and S. Guzy
Application
of Markov Chain Monte Carlo
Methods to Inverse Problems in PK/PD
D.
Kang and D. Verotta
Regenerative
Markov Chain Monte Carlo
Methods for Pharmacokinetic/ Pharmacodynamic Estimation
D.
Kang, A. Schumitzky and D.Z. D'Argenio
Vizstruct:
A Multidimensional
Visualization Algorithm for Gene Expression
M.
Ramanathan, L. Zhang and A. Zhang
Pharmacotherapy
Modeling and Simulation of Effects of Adherence,
Pharmacokinetic, and
Pharmacodynamic Characteristics in Development of Resistance to HIV
Regimens in Treatment-Naive Patients
A.
Hsu, R. Wada, B. Poland, E. Sun and R.G. Granneman
Mechanistic
PK/PD Modeling of
Antiretroviral Therapies in AIDS Clinical Trials
Y.
Huang and H. Wu
Dose
Individualization for High-Dose
Anti-Cancer Chemotherapy
G.L.
Rosner, P. Müller, F. Tang, T. Madden and B.S. Andersson
Toward
Model-Based Chemotherapy
Treatment Design
R.S.
Parker, J.M. Harrold, J.L. Eiseman, W.C. Zamboni, E.
Joseph, S. Strychor and M.J. Egorin
Control
of Uncertain Pharmacodynamic
Systems
K.
Park and D.Z. D'Argenio
